Our network of investigators and institutions, depth of oncology research experience, and familiarity with the inner workings and leadership of NCI and FDA make us well positioned to:
- Develop and manage phase I-III clinical trials in any area of oncology, from concept through completion
- Expedite clinical trial development through a nimble mechanism
- Initiate start-up activities through parallel operations
- Complete trials within established timelines
PrECOG Board of Managers
Peter O’Dwyer, M.D. is currently Professor of Medicine at the University of Pennsylvania School of Medicine and Director of the Experimental Therapeutics Program at the University of Pennsylvania Cancer Center.read more
Donna M. Marinucciread more
Patrick J. Flynn, M.D.
Bruce J. Giantonio, M.D.
Joseph A. Sparano, M.D.read more